Gene · 4860
Papers3,553
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,553
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Patient-reported outcomes and symptom clusters pattern of chemotherapy-induced toxicity in patients with early breast cancer. | PLoS One | 2024 | 38394281 | PubTator, text mining | PubMed |
| Successful use of dupilumab in recalcitrant pediatric atopic dermatitis-like graft-versus-host disease: A case series. | JAAD Case Rep | 2024 | 38292582 | PubTator, text mining | PubMed |
| Leveraging metabolic modeling and machine learning to uncover modulators of quiescence depth. | PNAS Nexus | 2024 | 38292544 | PubTator, text mining | PubMed |
| Intracellular Protein Delivery: Approaches, Challenges, and Clinical Applications. | BME Front | 2024 | 38282957 | PubTator, text mining | PubMed |
| Molecular features of luminal breast cancer defined through spatial and single-cell transcriptomics. | Clin Transl Med | 2024 | 38282415 | PubTator, text mining | PubMed |
| Osteopontin interacts with dendritic cells and macrophages in pulp inflammation: Comprehensive transcriptomic analysis and laboratory investigations. | Int Endod J | 2024 | 38279773 | PubTator, text mining | PubMed |
| NAD+ Metabolism-Related Gene Profile Can Be a Relevant Source of Squamous Cell Carcinoma Biomarkers. | Cancers (Basel) | 2024 | 38254798 | PubTator, text mining | PubMed |
| Enhanced Photocatalysis of Electrically Polarized Titania Nanosheets. | Nanomaterials (Basel) | 2024 | 38251135 | PubTator, text mining | PubMed |
| Mechanistic role of quercetin as inhibitor for adenosine deaminase enzyme in rheumatoid arthritis: systematic review. | Cell Mol Biol Lett | 2024 | 38225555 | PubTator, text mining | PubMed |
| Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma. | Virol J | 2024 | 38216938 | PubTator, text mining | PubMed |
| One-pot multicomponent polymerization towards heterocyclic polymers: a mini review. | RSC Adv | 2024 | 38192311 | PubTator, text mining | PubMed |
| Mendelian randomization identifies circulating proteins as biomarkers for age at menarche and age at natural menopause. | Commun Biol | 2024 | 38184718 | PubTator, text mining | PubMed |
| Spin-Crossing in the (Z)-Selective Alkyne Semihydrogenation Mechanism Catalyzed by Mo3S4 Clusters: A Density Functional Theory Exploration. | Inorg Chem | 2024 | 38173271 | PubTator, text mining | PubMed |
| 1H-NMR metabolomics analysis identifies hypoxanthine as a novel metastasis-associated metabolite in breast cancer. | Sci Rep | 2024 | 38167685 | PubTator, text mining | PubMed |
| Urinary biomarkers of exposure to organophosphate, pyrethroid, neonicotinoid insecticides and oxidative stress: A repeated measurement analysis among pregnant women. | Sci Total Environ | 2024 | 38145670 | PubTator, text mining | PubMed |
| Identification and structural validation of purine nucleoside phosphorylase from Plasmodium falciparum as a target of MMV000848. | J Biol Chem | 2024 | 38141766 | PubTator, text mining | PubMed |
| Role and function of plakophilin 3 in cancer progression and skin disease. | Cancer Sci | 2024 | 38048779 | PubTator, text mining | PubMed |
| Effect of the N-terminal extension in myosin essential light chain A1 on the mechanism of actomyosin ATP hydrolysis. | J Biol Chem | 2024 | 38042484 | PubTator, text mining | PubMed |
| Metabolic reprogramming driven by EZH2 inhibition depends on cell-matrix interactions. | J Biol Chem | 2024 | 37992808 | PubTator, text mining | PubMed |
| Mechanistic Insights into Cellular and Molecular Basis of Protein-Nanoplastic Interactions. | Small | 2024 | 37786309 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4860/papers?page=10